{"id":23012,"date":"2025-04-15T09:56:23","date_gmt":"2025-04-15T09:56:23","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/non-categorizzato\/genenta-presenta-la-sua-visione-strategica-al-montalcini-global-biotech-tour-di-doha\/"},"modified":"2025-04-17T11:27:40","modified_gmt":"2025-04-17T11:27:40","slug":"genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/","title":{"rendered":"Genenta presents strategic vision at Montalcini Global Biotech Tour in Doha"},"content":{"rendered":"<p class=\"\" data-start=\"319\" data-end=\"802\">The city of Doha, a vibrant hub of innovation in the Gulf, will host the next major international event for <strong data-start=\"466\" data-end=\"485\">Genenta Science<\/strong> (Nasdaq: GNTA), an Italo-American company specializing in cell-based therapies and a leader in immuno-oncology. CEO <strong data-start=\"602\" data-end=\"624\">Pierluigi Paracchi<\/strong> will speak on April 17, 2025, at the Qatar stop of the <em data-start=\"680\" data-end=\"712\">Montalcini Global Biotech Tour<\/em>, held at the Sheikh Fahad bin Jassim Al Thani Theatre, Ministry of Commerce and Industry.<\/p>\n<p class=\"\" data-start=\"804\" data-end=\"1128\">The event, hosted by <strong data-start=\"825\" data-end=\"856\">Ahmed bin Mohammed Al Sayed<\/strong>, Minister of State for Foreign Trade Affairs of Qatar, and <strong data-start=\"916\" data-end=\"963\">Italian Minister of Health Orazio Schillaci<\/strong>, serves as a strategic platform for dialogue between global biotech ecosystems. Opening remarks will be delivered by <strong data-start=\"1081\" data-end=\"1097\">Paolo Toschi<\/strong>, Ambassador of Italy to Qatar.<\/p>\n<h2 data-start=\"1130\" data-end=\"1170\">A Key Moment for Genenta\u2019s Expansion<\/h2>\n<p class=\"\" data-start=\"1172\" data-end=\"1637\">Genenta\u2019s participation in the forum comes at a pivotal time, following the announcement of a significant financing operation: a <strong data-start=\"1301\" data-end=\"1343\">\u20ac20 million Mandatory Convertible Bond<\/strong> subscribed by <strong data-start=\"1358\" data-end=\"1392\">ENEA Tech and Biomedical (ETB)<\/strong>, along with an additional <strong data-start=\"1419\" data-end=\"1433\">\u20ac3 million<\/strong> raised through an <strong data-start=\"1452\" data-end=\"1484\">at-the-market (ATM) facility<\/strong>. These funds will support the expansion of Genenta\u2019s pipeline, particularly the development of <strong data-start=\"1580\" data-end=\"1593\">Temferon\u2122<\/strong> for metastatic renal cell carcinoma (mRCC).<\/p>\n<p data-start=\"1172\" data-end=\"1637\">Temferon\u2122 is the company\u2019s proprietary platform and the cornerstone of its innovation. It is an investigational therapy based on genetically engineered hematopoietic stem cells, designed to act directly within the tumor microenvironment via bone marrow-derived myeloid cells, aiming to overcome immune tolerance and trigger a targeted and durable T cell response. After completing Phase 1 in newly diagnosed glioblastoma multiforme (GBM) patients with unmethylated MGMT promoter, Genenta launched a Phase 1\/2a trial for metastatic RCC in Q4 2024, which also includes combination therapy with immune checkpoint inhibitors.<\/p>\n<blockquote class=\"td_quote_box td_box_left\"><p><strong><span style=\"color: #111111; font-family: Roboto, sans-serif; font-size: 22px;\">About Genenta\u00a0<\/span><\/strong><\/p>\n<p class=\"\" data-start=\"3980\" data-end=\"4341\">Genenta is a clinical-stage biotech company based in Milan and New York, founded on the concept of using bone marrow-derived cells as smart delivery systems for immune payloads within tumors. Its therapies are designed as <strong data-start=\"4202\" data-end=\"4228\">one-time monotherapies<\/strong>, with additional potential to <strong data-start=\"4259\" data-end=\"4315\">boost the effectiveness of other approved treatments<\/strong> when used in combination.<\/p>\n<p class=\"\" data-start=\"4343\" data-end=\"4546\">With its innovative approach and strong institutional investor network, Genenta stands out as one of the most promising biotech firms in Europe \u2014 now poised to play a key role in the Middle East as well.<\/p>\n<\/blockquote>\n<h2 data-start=\"2262\" data-end=\"2301\">Italian Biotech on the Global Stage<\/h2>\n<p class=\"\" data-start=\"2303\" data-end=\"2953\">As part of the <em data-start=\"2318\" data-end=\"2350\">Montalcini Global Biotech Tour<\/em>, Paracchi will also speak in his capacity as <strong data-start=\"2396\" data-end=\"2495\">Moderator of the National Working Table for the Internationalization of Italian Biotech (NWTIB)<\/strong>, an initiative promoted by Italian Deputy Prime Minister and Minister of Foreign Affairs <strong data-start=\"2585\" data-end=\"2603\">Antonio Tajani<\/strong>. The session titled \u201cItalian Biotech &amp; Lifesciences Ecosystem\u201d will also feature <strong data-start=\"2685\" data-end=\"2705\">Massimo Carnelos<\/strong>, Head of the Office for Technological Innovation and Startups at the Italian Ministry of Foreign Affairs, and <strong data-start=\"2816\" data-end=\"2833\">Mario Scuderi<\/strong>, Senior Partner at <strong data-start=\"2853\" data-end=\"2876\">CDP Venture Capital<\/strong>, a long-standing investor in Genenta and participant in its 2021 Nasdaq IPO.<\/p>\n<p class=\"\" data-start=\"2955\" data-end=\"3350\">The program will also include presentations from the <strong data-start=\"3008\" data-end=\"3069\">Qatar Research, Development and Innovation Council (QRDI)<\/strong>, represented by <strong data-start=\"3086\" data-end=\"3109\">Dr. Sara A. Abdulla<\/strong>, and will conclude with <strong data-start=\"3134\" data-end=\"3217\">bilateral meetings with representatives of the Qatar Investment Authority (QIA)<\/strong>, the country\u2019s sovereign wealth fund managing over $475 billion in assets \u2014 a key strategic partner in international collaborations.<\/p>\n<h2 data-start=\"3352\" data-end=\"3398\">A Bridge Between Milan, New York, and Doha<\/h2>\n<p class=\"\" data-start=\"3400\" data-end=\"3690\">Genenta\u2019s invitation marks international recognition of the Milan-based biotech\u2019s pioneering role in the field of immuno-oncologic therapies. Qatar\u2019s interest in cutting-edge regenerative and personalized medicine creates fertile ground for future institutional and industrial partnerships.<\/p>\n<p style=\"text-align: right;\">\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>As one of the most promising players in immuno-oncology, Genenta, the Italo-American biotech company, outlines its roadmap before investors and international stakeholders in Qatar.<\/p>\n","protected":false},"author":32,"featured_media":23007,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[789],"tags":[],"class_list":{"0":"post-23012","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-deal-finance-en"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Genenta at Montalcini Global Biotech<\/title>\n<meta name=\"description\" content=\"The Italo-American biotech company outlines its roadmap before investors and international stakeholders in Qatar.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genenta at Montalcini Global Biotech\" \/>\n<meta property=\"og:description\" content=\"The Italo-American biotech company outlines its roadmap before investors and international stakeholders in Qatar.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-15T09:56:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-17T11:27:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/04\/AdobeStock_1396230309-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Valentina Parrella\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valentina Parrella\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/\"},\"author\":{\"name\":\"Valentina Parrella\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/01ec0cb017253bb5a698569292199800\"},\"headline\":\"Genenta presents strategic vision at Montalcini Global Biotech Tour in Doha\",\"datePublished\":\"2025-04-15T09:56:23+00:00\",\"dateModified\":\"2025-04-17T11:27:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/\"},\"wordCount\":571,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/04\/AdobeStock_1396230309-scaled.jpeg\",\"articleSection\":[\"Deal &amp; Finance\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/\",\"name\":\"Genenta at Montalcini Global Biotech\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/04\/AdobeStock_1396230309-scaled.jpeg\",\"datePublished\":\"2025-04-15T09:56:23+00:00\",\"dateModified\":\"2025-04-17T11:27:40+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/01ec0cb017253bb5a698569292199800\"},\"description\":\"The Italo-American biotech company outlines its roadmap before investors and international stakeholders in Qatar.\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/04\/AdobeStock_1396230309-scaled.jpeg\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/04\/AdobeStock_1396230309-scaled.jpeg\",\"width\":2560,\"height\":2560,\"caption\":\"DNA &amp; Drugs Red Background\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Genenta presents strategic vision at Montalcini Global Biotech Tour in Doha\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/01ec0cb017253bb5a698569292199800\",\"name\":\"Valentina Parrella\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"caption\":\"Valentina Parrella\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Genenta at Montalcini Global Biotech","description":"The Italo-American biotech company outlines its roadmap before investors and international stakeholders in Qatar.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/","og_locale":"en_US","og_type":"article","og_title":"Genenta at Montalcini Global Biotech","og_description":"The Italo-American biotech company outlines its roadmap before investors and international stakeholders in Qatar.","og_url":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2025-04-15T09:56:23+00:00","article_modified_time":"2025-04-17T11:27:40+00:00","og_image":[{"width":2560,"height":2560,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/04\/AdobeStock_1396230309-scaled.jpeg","type":"image\/jpeg"}],"author":"Valentina Parrella","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Valentina Parrella","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/"},"author":{"name":"Valentina Parrella","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/01ec0cb017253bb5a698569292199800"},"headline":"Genenta presents strategic vision at Montalcini Global Biotech Tour in Doha","datePublished":"2025-04-15T09:56:23+00:00","dateModified":"2025-04-17T11:27:40+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/"},"wordCount":571,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/04\/AdobeStock_1396230309-scaled.jpeg","articleSection":["Deal &amp; Finance"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/","url":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/","name":"Genenta at Montalcini Global Biotech","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/04\/AdobeStock_1396230309-scaled.jpeg","datePublished":"2025-04-15T09:56:23+00:00","dateModified":"2025-04-17T11:27:40+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/01ec0cb017253bb5a698569292199800"},"description":"The Italo-American biotech company outlines its roadmap before investors and international stakeholders in Qatar.","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/04\/AdobeStock_1396230309-scaled.jpeg","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/04\/AdobeStock_1396230309-scaled.jpeg","width":2560,"height":2560,"caption":"DNA &amp; Drugs Red Background"},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deal-finance-en\/genenta-presents-strategic-vision-at-montalcini-global-biotech-tour-in-doha\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"Genenta presents strategic vision at Montalcini Global Biotech Tour in Doha"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/01ec0cb017253bb5a698569292199800","name":"Valentina Parrella","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","caption":"Valentina Parrella"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/23012","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=23012"}],"version-history":[{"count":4,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/23012\/revisions"}],"predecessor-version":[{"id":23031,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/23012\/revisions\/23031"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/23007"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=23012"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=23012"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=23012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}